Skip to main content
. 2020 Nov 2;12:11133–11143. doi: 10.2147/CMAR.S275624

Figure 1.

Figure 1

The flow chart of the retrospective study of anlotinib in the treatment for elderly patients with previously treated extensive-stage small cell lung cancer.